Advances in Motion provides health care professionals with information about the latest breakthroughs, research and clinical advances from Massachusetts General Hospital.
EXPLORE OUR SPECIALTIES BROWSE OUR TOPICS SUBSCRIBE TO RECEIVE UPDATES
Featured In Cardiovascular
Clinical Diagnostic Tools May Misclassify HFpEF in Dyspnea Patients
Heart failure with preserved ejection fraction (HFpEF) can be challenging to diagnose, and recently risk scores have been developed to aid in diagnosis. For patients with chronic dyspnea, clinician-researchers in the Corrigan Minehan Heart Center sound a note of caution about using these scores including the HFA-PEFF algorithm and H2FPEF score to rule out HFpEF.
Featured In Neuroscience
Accelerating Treatments with the Healey Center ALS Platform Trial
Merit E. Cudkowicz, MD, MSc, chief of the Department Neurology and director of the Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital, discusses the Healey ALS Platform Trial, which aims to accelerate the discovery of new drug therapies for people with amyotrophic lateral sclerosis (ALS).
Featured In Urology
Prostate Cancer and Translational Research
Douglas Middleton Dahl, MD, is chief of the Division of Urologic Oncology at Massachusetts General Hospital, as well as director of Robotic Surgery. In this video, he discusses his translational research on prostate cancer cells and explains how this work will advance patient care.
Featured In Rheumatology
COVID-19 Patients with Rheumatic and Musculoskeletal Diseases at Substantial Risk of Poor Outcomes
Clinicians in the Division of Rheumatology, Allergy and Immunology found that for patients with rheumatic and musculoskeletal diseases who develop COVID-19, the risks of death and other severe outcomes have declined since early in the pandemic but remain considerable.
Featured In Geriatrics and Palliative Care
Continuum Project Trains Clinicians in Serious Illness Care
A Massachusetts General Hospital palliative care training program offers training and resources to prompt and document more conversations about serious illness.
The Latest Ophthalmology Advances
Mass Eye and Ear Sets Standards of Transparency and Accountability in Ophthalmology
The Department of Ophthalmology at Massachusetts Eye and Ear/Massachusetts General Hospital leads the ophthalmology community in developing and implementing outcome measures in every subspecialty area—setting the standard for transparency, accountability, and continued quality improvement in the field.
Female Hormonal Therapy Makes Only Small Contribution to Risk of Noninfectious Uveitis
In the first study of its kind, Lucia Sobrin, MD, MPH, and John H. Kempen, MD, MPH, PhD, MHS, of the Massachusetts Eye and Ear/Mass General Hospital Department of Ophthalmology, and colleagues found a low risk of noninfectious uveitis among women using hormonal contraceptives or menopausal hormone replacement therapy.
Contributing Physicians
Alice C. Lorch, MD, MPH
Assistant Professor of Ophthalmology, Harvard Medical School, Associate Chief for Quality for the Department of Ophthalmology, Mass Eye and Ear, Director, Harvard Ophthalmology Residency Training Program
Joan W. Miller, MD
Chief, Ophthalmology Department, Massachusetts General Hospital, Chief, Ophthalmology Department, Mass Eye and Ear, Ophthalmologist-in-Chief, Brigham and Women’s Hospital
Advances Specialties
OB/GYN
Vaginal Microbiome May Not Differ Between Black, White Postmenopausal Women
Lactobacillus species, which appear to protect against HIV infection and cervical cancer, are similarly abundant in vaginal samples from Black and whitepostmenopausal women, according to a molecular study by Caroline M. Mitchell, MD, MPH, and colleagues.
Orthopaedics
One-Quarter of Women in an Obstetric Population Report Severe Knee Dysfunction
Miho J. Tanaka, MD, of the Department of Orthopedic Surgery, and colleagues found that 26% of patients presenting to general obstetric clinics had severe knee pain, which could impede their ability to remain active during pregnancy.
Pulmonary and Critical Care
Ivacaftor Improves Skeletal Outcomes in Patients with Cystic Fibrosis
In the first prospective study of its kind, a team led by Massachusetts General Hopsital found evidence that ivacaftor improves bone density and microarchitecture in children and adults with cystic fibrosis who have the G551D-CFTR mutation.
April 21, 2021 - July 14, 2021
Grand Rounds: Mass General Cardiology Grand Rounds
The Massachusetts General Hospital Corrigan Minehan Heart Center prepares future health care professionals and trains providers in innovative therapies and care. As part of these efforts, the center hosts regular Grand Rounds presentations from thought leaders and researchers on important cardiology topics. Cardiology Grand Rounds is open to all healthcare professionals.
January 25-30, 2021
Conference: Mass General OB/GYN at SMFM Pregnancy Meeting 2021
The Society for Maternal-Fetal Medicine's Annual Meeting, The Pregnancy Meeting™, is the premier event for presenting and learning about cutting-edge science in obstetrics and provides participants the opportunity to connect with leaders and colleagues in maternal-fetal medicine. Learn more about the research presented by members of the Department of Obstetrics and Gynecology at Massachusetts General Hospital.
Brain mechanisms of vagus nerve stimulation and stress reduction training for migraine
The study involves brain imaging including fMRI and PET-MR, an 8-week stress reduction intervention, and at-home practice. You will also complete daily migraine diaries.
Understanding Daily Changes in Body Dysmorphic Disorder Risk Using Smartphones
Do you think about your appearance nonstop or find yourself stuck in front of the mirror? You may be eligible to participate in a smartphone study on day-to-day factors that contribute to distress in body dysmorphic disorder (BDD).
